Contact: [email protected]
| Title | Tumor Type | Line | Study information |
|---|---|---|---|
| RAINBO-green | Endometrial pMMR | Adj | Adjuvant radiotherapy + durvalumab q4w x 13 (experimental arm) vs. adjuvant radiotherapy +/- chemotherapy (standard arm) |
| R4018-ONC-1721 | Ovarian (epithelial) | >1L | REGN4018 IV QW +/- cemiplimab IV Q3W ; at least 1 prior platinum line for which progression |
| CIP-S25470 | Multiple | Cancer during pregnancy and in first 5 years after delivery | |
| CIP-S62388 | Multiple | Cancer during pregnancy | |
| VS-6766-301 (Verastem) | Low grade ovarian | >1L | Avutometinib (VS-6766) + Defactinib (VS-6063) vs investigator choice; currently only recruiting KRAS mutant patients |